Insider Trading History of Christmas Patrick J.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Christmas Patrick J. since year 2005. The trader's CIK number is 1521123. At the time of the last reporting, Christmas Patrick J. was the SVP, General Counsel of Regenxbio Inc. . (stock ticker symbol RGNX). See this page for all insider trading activities at Regenxbio Inc. .


Stock purchases, sales, and option exercises reported by insider Christmas Patrick J. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-04-18 RGNX Regenxbio Inc. Option Ex 5,000 15.80 79,000
2019-04-18 RGNX Regenxbio Inc. Sale 5,000 54.09 270,475
2018-12-18 RGNX Regenxbio Inc. Option Ex 5,000 12.10 60,500
2018-12-18 RGNX Regenxbio Inc. Sale 5,000 47.87 239,350
2018-11-07 RGNX Regenxbio Inc. Sale 15,000 72.06 1,080,900
2018-10-18 RGNX Regenxbio Inc. Option Ex 5,000 12.10 60,500
2018-10-18 RGNX Regenxbio Inc. Sale 5,000 61.96 309,815
2018-08-20 RGNX Regenxbio Inc. Option Ex 5,000 12.10 60,500
2018-08-20 RGNX Regenxbio Inc. Sale 5,000 66.08 330,400
2018-06-18 RGNX Regenxbio Inc. Option Ex 5,000 12.10 60,500
2018-06-19 RGNX Regenxbio Inc. Option Ex 1,528 12.10 18,488
2018-06-18 RGNX Regenxbio Inc. Sale 5,000 56.08 280,400
2018-05-09 RGNX Regenxbio Inc. Option Ex 15,000 12.10 181,500
2018-05-10 RGNX Regenxbio Inc. Option Ex 15,000 12.10 181,500
2018-05-09 RGNX Regenxbio Inc. Sale 15,000 43.00 645,000
2018-04-11 RGNX Regenxbio Inc. Option Ex 10,000 12.10 121,000
2018-04-11 RGNX Regenxbio Inc. Sale 10,000 39.00 390,000
2018-04-09 RGNX Regenxbio Inc. Option Ex 10,000 12.10 121,000
2018-04-09 RGNX Regenxbio Inc. Sale 10,000 34.00 340,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Christmas Patrick J. (SVP, General Counsel of Regenxbio Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.